|
|
|
|
|
by DiggyJohnson
971 days ago
|
|
As someone who partakes in psychedelics to a moderate degree, I don’t think it makes any sense at all to dismiss the very many negative outcomes as “no evidence”. Perhaps it’s under-researched, but your comment strikes me as ideological and/or hyperbole. Like with all treatments, it’s a careful balance of whether the risks are worth the positive health outcomes. But there’s no sense in denying that psychedelics, and thus psychedelic mental health treatment programs, have no evidence of potential issues. |
|
> Purdue Pharma created false advertising documents to provide doctors and patients illustrating that time-released OxyContin was less addictive than other immediate release alternatives. Furthermore, they sought out doctors who were more likely to prescribe opioids and encouraged them to prescribe OxyContin because it was safer. They did this because OxyContin quickly became a cash cow for the company. (https://oversight.house.gov/release/comer-purdue-pharma-and-...)
A degree of malfeasance in the same realm as Big Tobacco's denials of the risks and addictiveness of smoking:
https://www.cbsnews.com/news/big-tobacco-kept-cancer-risk-in... https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879177/
Although, perhaps could be considered worse since it occurred more recently in a theoretically more highly regulated market than mid 1900's tobacco.